[1] |
Jeon MJ, Kim WG, Choi YM,et al.Features predictive of distant metastasis in papillary thyroid microcarcinoma[J].Thyroid,2016,26(1): 161-168.
|
[2] |
Nickel B, Brito JP, Moynihan R, et al. Patients’ experiences of diagnosis and management of papillary thyroid microcarcinoma: a qualitative study[J]. BMC Cancer, 2018, 18(1): 242.
|
[3] |
田文,赵文新.腔镜分化型甲状腺癌根治术的难点和争议[J/CD].中华普外科手术学杂志(电子版),2018,12(6): 451-454.
|
[4] |
孙辉,李世杰,付言涛.分化型甲状腺癌功能性或传统性颈淋巴结清扫的利弊[J/CD].中华普外科手术学杂志(电子版),2018,12(6): 455-457.
|
[5] |
Vlassopoulou V, Vryonidou A, Paschou SA, et al. No considerable changes in papillary thyroid microcarcinoma characteristics over a 30-year time period[J].BMC Res Notes, 2016, 9: 252.
|
[6] |
Grigerová M, Griger M, Mojtová E, et al.The course of differentiated thyroid microcarcinoma in patients treated by different therapeutic strategies[J].Vnitr Lek,2016,62(9 Suppl 3): 17-21.
|
[7] |
胡敏敏,胡光晔,李志宇,等.甲状腺癌术中应用纳米碳示踪剂对甲状旁腺的保护作用[J].中华内分泌外科杂志,2017,11(2): 150-153.
|
[8] |
Kim TY, Shong YK. Active Surveillance of Papillary Thyroid Microcarcinoma: A Mini-Review from Korea[J]. Endocrinol Metab, 2017, 32(4): 399-406.
|
[9] |
Conzo G, Tartaglia E, Avenia N, et al. Role of prophylactic central compartment lymph node dissection in clinically N0 differentiated thyroid cancer patients: analysis of risk factors and review of modern trends[J]. World J Surg Oncol, 2016, 14(1): 149.
|
[10] |
杜峻峰,安然,李世拥.分化型甲状腺癌术中纳米碳示踪对颈淋巴结清扫的指导意义[J/CD].中华普外科手术学杂志(电子版),2018,12(6): 462-465.
|
[11] |
Wang L, Yang D, Lv JY, et al. Application of carbon nanoparticles in lymph node dissection and parathyroid protection during thyroid cancer surgeries: a systematic review and meta-analysis[J]. Onco Targets Ther, 2017,10(1): 1247-1260.
|
[12] |
Sessa L, Lombardi CP, Crea CD, et al. Risk Factors for Central Neck Lymph Node Metastases in Micro-Versus Macro-Clinically Node Negative Papillary Thyroid Carcinoma[J]. World J Surg, 2017, 42(3): 623-629.
|
[13] |
Goran M, Pekmezovic T, Markovic I, et al. Lymph node metastases in clinically N0 patients with papillary thyroid microcarcinomas-a single institution experience[J]. J BUON,2017, 22(1): 224-231.
|
[14] |
Vorasubin N, Nguyen C, Wang M.Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: A meta-analysis[J]. Ear Nose Throat J, 2016, 95(2): 73-77.
|
[15] |
Liu LS, Liang J, Li JH, et al. The incidence and risk factors for central lymph node metastasis in cN0 papillary thyroid microcarcinoma: a meta-analysis[J].Eur Arch Otorhinolaryngol, 2016, 274(3): 1327-1338.
|
[16] |
Wells SA Jr, Asa SL, Dralle H, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma[J]. Thyroid,2015, 25(6): 567-610.
|
[17] |
Jeon MJ, Chung MS, Kwon H, et al. Features of papillary thyroid microcarcinoma associated with lateral cervical lymph node metastasis[J]. Clin Endocrinol,2017, 86(6): 845-851.
|
[18] |
Gschwandtner E, Klatte T, Swietek N, et al. Increase of papillary thyroid microcarcinoma and a plea for restrictive treatment: A retrospective study of 1,391 prospective documented patients[J]. Surgery, 2016, 159(2): 503-511.
|